Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$6.23B
-1.2% from 2023
Prescriptions
6.7M
$935.73 per claim
Patients
1.3M
348,034 prescribers
Total spending, 2024
$6.23B
$4,717.75 per patient
Medicare prescription drug plans paid $6.23B for Xarelto in 2024, for 6,658,485 prescriptions and refills to 1,320,644 patients (down 1.2% from 2023). The average cost per claim was $935.73.
California had the highest Medicare cost for Xarelto in 2024: $495.2M for 511,553 claims, followed by Florida ($475.3M).
Cindy S Kennedy, pharmacist in Charlotte, NC, had the highest Medicare cost for Xarelto in 2024: 1,585 claims costing $2.5M.
Xarelto is made by Johnson & Johnson (JNJ), listed in the Medicare spending data as Janssen Pharm..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Cindy S Kennedy Charlotte, NC | Pharmacist | 1,585 | 473 | $2.5M |
| Huong K Ha Sepulveda, CA | Pharmacist | 1,856 | 660 | $2.4M |
| Prakash D Shah Milwaukee, WI |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 339,918 | 6,523,366 | 1,311,050 | $5.77B |
| 2023 | 343,437 | 6,651,363 | 1,323,475 | $6.31B |
| 2024 | 348,034 | 6,658,485 | 1,320,644 | $6.23B |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Cardiology |
| 1,950 |
| 478 |
| $2.4M |
| Jennifer L Tresser Martinez, CA | Pharmacist | 1,680 | 633 | $2.3M |
| Mayer Rashtian Pasadena, CA | Clinical Cardiac Electrophysiology | 1,800 | 462 | $2.1M |
| David H Lau New York, NY | Cardiology | 2,571 | 419 | $2.0M |
| Carmen Wong Union City, CA | Pharmacist | 1,387 | 496 | $1.7M |
| Jordan Wong San Francisco, CA | Pharmacist | 1,318 | 449 | $1.7M |
| Yili Huang Elmhurst, NY | Cardiology | 1,603 | 405 | $1.5M |
| Cres P Miranda Jr. Las Vegas, NV | Cardiology | 1,138 | 343 | $1.4M |
| Hyeon Hye Lee Cupertino, CA | Pharmacist | 992 | 370 | $1.3M |
| William H Skinner Lexington, KY | Cardiology | 1,173 | 269 | $1.3M |
| Ajay Tuli Tucson, AZ | Interventional Cardiology | 975 | 268 | $1.3M |
| Michael C Liou New York, NY | Interventional Cardiology | 1,537 | 269 | $1.3M |
| David H Hoch Roslyn, NY | Clinical Cardiac Electrophysiology | 969 | 304 | $1.2M |
| Cash Casey Elmhurst, IL | Clinical Cardiac Electrophysiology | 1,032 | 240 | $1.2M |
| Hossein Amirani Wichita, KS | Cardiology | 1,261 | 248 | $1.2M |
| Harry R Hawthorne Alexandria, LA | Clinical Cardiac Electrophysiology | 1,472 | 288 | $1.2M |
| Maria R Peluso Winston Salem, NC | Pharmacist | 754 | 262 | $1.2M |
| Lynne Hung Mission Viejo, CA | Clinical Cardiac Electrophysiology | 1,119 | 285 | $1.2M |
| Avichai Eres Lexington, KY | Cardiology | 968 | 254 | $1.2M |
| Mauricio Melhado West Palm Beach, FL | Cardiology | 1,473 | 305 | $1.2M |
| Dharmesh S Patel Southaven, MS | Cardiology | 1,243 | 319 | $1.2M |
| Paul E Bejarano Tucson, AZ | Cardiology | 822 | 229 | $1.1M |
| Ronald G Ryder Hamilton, NJ | Cardiology | 908 | 226 | $1.1M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Janssen Pharm. JNJ | 6,660,246 | $6.23B |